L. B. A. Van De Putte spends much of his time researching Rheumatoid arthritis, Internal medicine, Arthritis, Surgery and Prospective cohort study. His Rheumatoid arthritis research includes themes of Physical therapy, Methotrexate and Autoimmune disease. His research integrates issues of Longitudinal study and Radiography in his study of Physical therapy.
His research in the fields of Erythrocyte sedimentation rate, Chemotherapy and Clinical trial overlaps with other disciplines such as Sulfasalazine. His Arthritis study incorporates themes from Pathology, Albumin, Acute-phase protein, Severity of illness and C-reactive protein. His Surgery research integrates issues from Placebo, Epidemiology and Urology.
L. B. A. Van De Putte mainly investigates Rheumatoid arthritis, Internal medicine, Immunology, Arthritis and Surgery. His Rheumatoid arthritis study combines topics in areas such as Autoimmune disease, Methotrexate, Physical therapy and Chemotherapy. The study incorporates disciplines such as Azathioprine and Pharmacology in addition to Methotrexate.
Many of his studies involve connections with topics such as Disease and Physical therapy. His work in Internal medicine covers topics such as Gastroenterology which are related to areas like Aurothioglucose. His Arthritis research is multidisciplinary, incorporating perspectives in Inflammation, Prospective cohort study, Pathology, Cartilage and In vivo.
L. B. A. Van De Putte mainly focuses on Rheumatoid arthritis, Internal medicine, Immunology, Surgery and Methotrexate. L. B. A. Van De Putte specializes in Rheumatoid arthritis, namely Rheumatoid factor. His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine.
He has included themes like Genetics, Locus and Allele frequency in his Immunology study. His Methotrexate research is multidisciplinary, incorporating elements of Toxicity, Area under the curve, Pharmacology and Pharmacotherapy. His Chemotherapy research incorporates themes from Autoimmune disease, Connective tissue disease and Immunopathology.
The scientist’s investigation covers issues in Internal medicine, Rheumatoid arthritis, Surgery, Placebo and Adverse effect. His study in Rheumatoid arthritis is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology, Methotrexate and Arthritis. His Arthritis study results in a more complete grasp of Immunology.
His study on Hematopoietic stem cell transplantation, Autologous stem-cell transplantation and Transplantation is often connected to Application methods as part of broader study in Surgery. L. B. A. Van De Putte works mostly in the field of Placebo, limiting it down to concerns involving Disease-modifying antirheumatic drug and, occasionally, Injection site reaction, Randomized controlled trial, Rheumatology, Tolerability and Phases of clinical research. The various areas that L. B. A. Van De Putte examines in his Adverse effect study include Immune-mediated inflammatory diseases, Tumor necrosis factor α, Interleukin 1 family and Consensus conference.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Modified disease activity scores that include twenty-eight-joint counts : development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
M.L.L. Prevoo;M.A. van 't Hof;H.H. Kuper;M.A. van Leeuwen.
Arthritis & Rheumatism (1995)
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria
A.M. van Gestel;M.L.L. Prevoo;M.A. van 't Hof;M.H. van Rijswijk.
Arthritis & Rheumatism (1996)
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
G.A. Schellekens;B.A. de Jong;F.H.J. van den Hoogen;L.B.A. van de Putte.
Journal of Clinical Investigation (1998)
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
D M van der Heijde;M A van 't Hof;P L van Riel;L A Theunisse.
Annals of the Rheumatic Diseases (1990)
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.
E.J.A. Kroot;B.A.W. de Jong;M.A. van Leeuwen;H.L. Swinkels.
Arthritis & Rheumatism (2000)
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed
L B A van de Putte;C Atkins;M Malaise;J Sany.
Annals of the Rheumatic Diseases (2004)
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system
M.C.W. Creemers;M.J.A.M. Franssen;M.A. van 't Hof;F.W.J. Gribnau.
Annals of the Rheumatic Diseases (2005)
Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis : a randomized, controlled study
R. F. J. M. Laan;P. L. C. M. Van Riel;L. B. A. Van De Putte;L. J. T. O. Van Erning.
Annals of Internal Medicine (1993)
REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE DISEASE ACTIVITY SCORE
M.L.L. Prevoo;A.M. van Gestel;M.A. van 't Hof;M.H. van Rijswijk.
Rheumatology (1996)
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study
A E van Ede;R F Laan;M J Rood;T W Huizinga.
Arthritis & Rheumatism (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Radboud University Nijmegen
Radboud University Nijmegen Medical Centre
Radboud University Nijmegen
University of Leeds
Leiden University Medical Center
Vrije Universiteit Amsterdam
Radboud University Nijmegen
Hospital Universitario La Paz
University of Pisa
Leiden University Medical Center
Roma Tre University
Jilin University
Sogang University
Boston College
Osaka University
University of Oxford
Pennsylvania State University
University of Minnesota
Cornell University
Université Savoie Mont Blanc
Karolinska Institute
VA Boston Healthcare System
Johns Hopkins University
Finnish Environment Institute
London School of Economics and Political Science
Arizona State University